China-based medical diagnostics device developer Aohua Endoscopy has raised RMB300m ($43.7m) in series D funding from investors including Legend Capital, the investment firm created by conglomerate Legend Holdings, China Money Network has reported.
Private equity firm Lyfe Capital led the round, investing together with venture capital firm Qiming Venture Partners.
Aohua produces endoscopes, long winding tubes with fitted cameras that are fed into a patient’s body in order to view a particular internal part and analyse the disorders with which they are affected.
The series D funding will support the introduction of the company’s next iteration of endoscope systems as well as an international expansion that has so far included the acquisitions of UK-based Vesco in May 2018 and Germany-based Wisap Medical in June.
VC fund Cenova Ventures provided an undisclosed amount of series A funding for Aohua in 2013 before Legend Capital invested RMB100m the following year, according to China Money Network, the two subsequently joining Qiming VC for a RMB200m series C round.
Image courtesy of Aohua Endoscopy Co., Ltd.
